Literature DB >> 11344118

Recombinant Sendai virus-mediated gene transfer to vasculature: a new class of efficient gene transfer vector to the vascular system.

I Masaki1, Y Yonemitsu, K Komori, H Ueno, Y Nakashima, K Nakagawa, M Fukumura, A Kato, M K Hasan, Y Nagai, K Sugimachi, M Hasegawa, K Sueishi.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11344118     DOI： 10.1096/fj.00-0460fje

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  13 in total

1.  A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Masayuki Shirakura; Tsuyoshi Tokusumi; Takahiro Hirata; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Tsuyoshi Tokusumi; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave.

Authors:  Brenna Sharp; Ramya Rallabandi; Patricia Devaux
Journal:  Mol Diagn Ther       Date:  2022-06-28       Impact factor: 4.476

4.  Development of viral vectors for use in cardiovascular gene therapy.

Authors:  Paul D Williams; Parisa Ranjzad; Salik J Kakar; Paul A Kingston
Journal:  Viruses       Date:  2010-01-27       Impact factor: 5.818

5.  Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions.

Authors:  Chad C Macarthur; Andrew Fontes; Namritha Ravinder; David Kuninger; Jasmeet Kaur; Matthew Bailey; Antje Taliana; Mohan C Vemuri; Pauline T Lieu
Journal:  Stem Cells Int       Date:  2012-03-22       Impact factor: 5.443

Review 6.  RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

Authors:  Juan A Bernal
Journal:  J Cardiovasc Transl Res       Date:  2013-07-13       Impact factor: 4.132

Review 7.  Cellular unfolded protein response against viruses used in gene therapy.

Authors:  Dwaipayan Sen; Balaji Balakrishnan; Giridhara R Jayandharan
Journal:  Front Microbiol       Date:  2014-05-26       Impact factor: 5.640

Review 8.  Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.

Authors:  Mahito Nakanishi; Makoto Otsu
Journal:  Curr Gene Ther       Date:  2012-10       Impact factor: 4.391

9.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.

Authors:  Noemi Fusaki; Hiroshi Ban; Akiyo Nishiyama; Koichi Saeki; Mamoru Hasegawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

10.  Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions.

Authors:  Yoshikazu Kishino; Tomohisa Seki; Jun Fujita; Shinsuke Yuasa; Shugo Tohyama; Akira Kunitomi; Ryota Tabei; Kazuaki Nakajima; Marina Okada; Akinori Hirano; Hideaki Kanazawa; Keiichi Fukuda
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.